CELL FOUNDRIES
DEAD

Serial Number

88873545

Owner

Cellares Corporation

Attorney

Sean Ploen

Filing Date

Apr 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELL FOUNDRIES Trademark

Serial Number: 88873545

CELL FOUNDRIES is a trademark filed by Cellares Corporation on April 15, 2020. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cellares Corporation (38 trademarks)

South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 15, 2020

Registration Date

Not Registered

Goods & Services

Custom manufacture of therapeutic drugs by pharmaceutical compounders in the field of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical and veterinary preparations by pharmaceutical compounders for health care for the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicines for human purposes, medicines for experimental purposes, biological pharmaceuticals for experimental purposes, pharmaceuticals for cell therapy and medicines for innovative therapies

Downloadable computer software for accessing a database featuring information in the medical field, specifically, stem cell therapy related information; Downloadable software applications for telephones, tablets, computers, namely, software for allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers, namely, software for allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; downloadable electronic publications in the nature of electronic questionnaires on the area of advanced therapy and cell therapy medications; none of the foregoing in the field of pharmaceutical and veterinary products

Installation, repair and maintenance services of medical and scientific equipment for the manufacturing of autologous and allogeneic biological cell therapies

Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; reagents for scientific and research use

Stem cell therapy services; autologous and allogeneic cell therapy services for medical treatment purposes, namely, genetic testing of humans for health assessment, diagnostic or treatment purposes, all for medical purposes; autologous and allogeneic cell therapy services for the treatment of hematological malignancies; medical services, namely, administration of cell therapy services for the treatment of hematological malignancies

Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes and disposable single-use containers, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form in the nature of contaminated medical waste for medical use

Research and development services in the field of cell therapies; Scientific research in the field of human and animal cell therapy; Providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Medical and scientific research in the field of cell therapy; technical assessments relating to design, namely, technical design consultation in the field of manufacture of advanced therapy and cell therapy medications; Technical research in the field of manufacture of advanced therapy and cell therapy medications; Software as a service (SaaS) services featuring software for assisting in the diagnosis of medical conditions in relation to advanced therapy and cell therapy medications; Cloud computing featuring software for use in assisting in the diagnosis of medical conditions; Providing search engines for the internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, the creation of websites for others used for registered users of virtual communities that allows the organization of groups and events, the participation to discussion, and the involvement into the social, business and community networking in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, hosting of electronic online web facilities for third parties to organize colloquiums, events and interactive discussions via communication networks in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Hosting digital content for users on the Internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Designing web pages for others, namely, online forums in the field of manufacture of advanced therapy and cell therapy

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jan 11, 2022 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jan 11, 2022 ABN3
EXPARTE APPEAL TERMINATED
Jan 11, 2022 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Nov 29, 2021 EXFB
ASSIGNED TO EXAMINER
Sep 29, 2021 DOCK
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Sep 16, 2021 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Sep 16, 2021 GECD
ACTION CONTINUING FINAL - COMPLETED
Sep 16, 2021 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2021 CRFA
ASSIGNED TO LIE
Aug 13, 2021 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 10, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 10, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 10, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 10, 2021 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2020 NWOS
NEW APPLICATION ENTERED
Apr 18, 2020 NWAP